NCT/Study#

2021-0512

Clinical Efficacy and Mechanisms of Resistance to Polatuzumab Vedotin in Patients with Large B-cell Lymphoma After CAR T-cell therapy

Clinical Efficacy and Mechanisms of Resistance to Polatuzumab Vedotin in Patients with Large B-cell Lymphoma After CAR T-cell therapy

DISEASE GROUP:
Lymphoma
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: